
Sign up to save your podcasts
Or
In this episode of the IJGC podcast, Editor-in-Chief Dr. Pedro Ramirez is joined by Dr. Antonio González-Martín to discuss the results of overall survival in the PRIMA trial. Dr. Antonio González-Martín specializes in the treatment of gynaecological and breast cancer and is the chairman of GEICO (Spanish group for investigation in ovarian and gynaecological cancer). He is also the representative of GEICO in ENGOT (European Network for Gynaecological Oncological Trials), and was the President of this Group for the period 2018-2020. In addition, he is one of the representatives of GEICO in Gynaecologic Cancer InterGroup (GCIG), and has served as chair of the ovarian cancer committee for the period 2014-2020. He is also a member of the board of the Spanish Society of Medical Oncology (SEOM), and a member of GEICAM and SOLTI breast cancer cooperative groups.
5
22 ratings
In this episode of the IJGC podcast, Editor-in-Chief Dr. Pedro Ramirez is joined by Dr. Antonio González-Martín to discuss the results of overall survival in the PRIMA trial. Dr. Antonio González-Martín specializes in the treatment of gynaecological and breast cancer and is the chairman of GEICO (Spanish group for investigation in ovarian and gynaecological cancer). He is also the representative of GEICO in ENGOT (European Network for Gynaecological Oncological Trials), and was the President of this Group for the period 2018-2020. In addition, he is one of the representatives of GEICO in Gynaecologic Cancer InterGroup (GCIG), and has served as chair of the ovarian cancer committee for the period 2014-2020. He is also a member of the board of the Spanish Society of Medical Oncology (SEOM), and a member of GEICAM and SOLTI breast cancer cooperative groups.
61 Listeners
17,197 Listeners
11,852 Listeners
43,329 Listeners
248 Listeners
110,824 Listeners
7,003 Listeners
8,007 Listeners
18 Listeners
15,363 Listeners